University of Sussex
Browse

File(s) under permanent embargo

Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat

journal contribution
posted on 2023-06-08, 22:58 authored by Maria Meringolo, Valentina Brusadin, Maria T De Luca, Christian Montanari, Christian L Montanari, Letizia Antonilli, Paolo Nencini, Aldo Badiani
RATIONALE Heroin is rapidly metabolized to morphine that in turn is transformed into morphine-3-glucuronide (M3G), an inactive metabolite at mu-opioid receptor (MOR), and morphine-6-glucuronide (M6G), a potent MOR agonist. We have found that rats that had received repeated intraperitoneal injections of heroin exhibit measurable levels of M6G (which is usually undetectable in this species). OBJECTIVE The goal of the present study was to investigate whether M6G synthesis can be induced by intravenous (i.v.) heroin self-administration (SA). MATERIALS AND METHODS Rats were trained to self-administer either heroin (50 µg/kg per infusion) or saline for 20 consecutive 6-h sessions and then challenged with an intraperitoneal challenge of 10 mg/kg of heroin. Plasma levels of heroin, morphine, 6-mono-acetyl morphine, M3G, and M6G were quantified 2 h after the challenge. In vitro morphine glucuronidation was studied in microsomal preparations obtained from the liver of the same rats. RESULTS Heroin SA induced the synthesis of M6G, as indicated by detectable plasma levels of M6G (89.7?±?37.0 ng/ml vs. 7.35?±?7.35 ng/ml after saline SA). Most important, the in vitro V (max) for M6G synthesis was correlated with plasma levels of M6G (r (2)?=?0.78). Microsomal preparations from saline SA rats produced negligible amounts of M6G. CONCLUSION Both in vivo and in vitro data indicate that i.v. heroin SA induces the synthesis of M6G. These data are discussed in the light of previous studies conducted in heroin addicts indicating that in humans heroin enhances the synthesis of the active metabolite of heroin and morphine.

History

Publication status

  • Published

File Version

  • Published version

Journal

Psychopharmacology

ISSN

1432-2072

Publisher

Springer

Issue

2

Volume

221

Page range

195-203

Department affiliated with

  • Psychology Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2015-10-28

First Compliant Deposit (FCD) Date

2015-10-28

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC